M. Reardon

发表

Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter Paradigms

R. Puri, J. Rodés‐Cabau, I. Dykun, 2023, Structural heart : the journal of the Heart Team.

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.

A. Yoganathan, J. Leipsic, M. Mack, 2018, Circulation.

1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.

D. Adams, H. Dauerman, T. Bajwa, 2017, JACC. Cardiovascular interventions.

Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.

P. Teirstein, J. Bavaria, C. Hengstenberg, 2019, Circulation.

Early Experience With New Transcatheter Mitral Valve Replacement.

M. Mack, D. Adams, R. Rajani, 2018, Journal of the American College of Cardiology.

4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.

P. Teirstein, H. Gada, B. Ramlawi, 2023, Journal of the American College of Cardiology.

Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.

B. Kiaii, N. Van Mieghem, H. Gada, 2024, JACC. Cardiovascular interventions.

Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

J. Popma, M. Reardon, Tanvir K Bajwa, 2023, Frontiers in Cardiovascular Medicine.

Reply: Concerns Regarding the Report of 3-Year Outcomes of the Evolut Low Risk Trial.

John K. Forrest, M. Reardon, 2023, Journal of the American College of Cardiology.

Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.

D. Adams, J. Afilalo, G. Deeb, 2016, Journal of the American College of Cardiology.

Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.

N. Van Mieghem, S. Chetcuti, William M. Merhi, 2024, JACC. Cardiovascular interventions.

National Variability in Pacemaker Implantation Rate Following TAVR

V. Thourani, S. Kodali, H. Gada, 2024, JACC: Cardiovascular Interventions.

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

J. Leipsic, H. Dauerman, J. Popma, 2023, Circulation. Cardiovascular interventions.

Mitral valve replacement with preservation of the subvalvular apparatus.

T. David, M. Reardon, M J Reardon, 1999, Current opinion in cardiology.

Computed Tomography–Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch: Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in the SURTAVI Trial

G. Deeb, J. Oh, J. Popma, 2019, Circulation. Cardiovascular interventions.

3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.

J. Kauten, H. Gada, S. Chetcuti, 2024, JACC. Cardiovascular interventions.